The FDA has granted Warner Chilcott approval for its norethindrone acetate and ethinyl estradiol chewable tablets and ferrous fumarate tablets. The oral contraceptives are expected to be released in August.
Published in Brief:
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Sr. Business Systems Analyst||
|Sr. Reimbursement Analyst||
Olympus America Inc.
|Leadership Recruiting Manager||
|Strategic Partner Relationship Executive||
Geisinger Health System